
| Serial Number | 79425879 |
| Word Mark | NANOSYRINX |
| Filing Date | Tuesday, March 25, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, October 27, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Micro-organisms, cultures and preparations of micro-organisms other than for medical and veterinary use; chemical products and substances for use in science and industry; chemical products and substances for in vitro use; chemical reagents for identification of microorganisms, other than for medical or veterinary use; cell cultures except for medical and veterinary purposes; chemicals for analysis in laboratories; media for cell culture for use in the biotechnological industry; cultures of cell media [other than for medical or veterinary use]; nutritive agents for processing living cells [other than for medical use]; nutrition agents for processing living cells [other than for medical use]; biological preparations for use in cell cultures other than for medical or veterinary use; living microorganisms, other than for medical or veterinary use; chemicals and polymers for use in the pharmaceutical industry; proteins for scientific research and development; peptide preparations; proteins for use in science; laboratory reagents for scientific use; laboratory reagents for intracellular delivery of peptides, proteins, enzymes, gene editing enzymes, antibodies or antibody fragments. |
| Goods and Services | Scientific and technological services and research and design relating thereto; research services; biotechnological research services; drug discovery services; clinical trials; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; medical laboratories; medical laboratory services; medical research; medical research services; pharmaceutical drug development services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of vaccines and medicines; research of pharmaceuticals; research relating to medicines; research relating to pharmaceuticals; scientific investigations for medical purposes; scientific research and development; scientific research in the field of pharmacy; services for assessing the efficacy of pharmaceuticals; research and development in the field of drug delivery; research and development in the field of gene editing; information, advisory and consultancy services relating to all of the aforesaid. |
| Goods and Services | Pharmaceutical and veterinary preparations; pharmaceutical preparations and substances; pharmaceutical compositions and preparations; pharmaceutical preparations for intracellular delivery of drugs; veterinary preparations for intracellular delivery of drugs; pharmaceutical preparations for intracellular delivery of antibodies; veterinary preparations for intracellular delivery of antibodies; pharmaceutical preparations for intracellular delivery of enzymes; veterinary preparations for intracellular delivery of enzymes; pharmaceutical preparations for intracellular delivery of antibody fragments; veterinary preparations for intracellular delivery of antibody fragments; pharmaceutical preparations for gene editing; veterinary preparations for gene editing; pharmaceutical preparations for intracellular delivery of therapeutic substances focused on the development of RNA therapies; veterinary preparations for intracellular delivery of therapeutic substances focused on the development of RNA therapies; pharmaceutical preparations for intracellular delivery of therapeutic substances focused on non-viral delivery technology; veterinary preparations for intracellular delivery of therapeutic substances focused on non-viral delivery technology; pharmaceutical preparations for intracellular delivery of nucleic acids; veterinary preparations for intracellular delivery of nucleic acids; pharmaceutical preparations for intracellular delivery of proteins; veterinary preparations for intracellular delivery of proteins; pharmaceutical preparations for intracellular delivery of peptides; veterinary preparations for intracellular delivery of peptides; pharmaceutical preparations for intracellular delivery of small molecules; veterinary preparations for intracellular delivery of small molecules; pharmaceutical substances for intracellular delivery of drugs; pharmaceutical substances for gene editing; pharmaceutical substances for intracellular delivery of therapeutic substances focused on the development of RNA therapies; pharmaceutical substances for intracellular delivery of therapeutic substances focused on non-viral delivery technology; pharmaceutical substances for intracellular delivery of nucleic acids; pharmaceutical substances for intracellular delivery of proteins; pharmaceutical preparations for intracellular delivery peptides; pharmaceutical substances for intracellular delivery of peptides; pharmaceutical substances for intracellular delivery of small molecules; drug delivery agents; drug delivery agents that facilitate the delivery of pharmaceutical preparations; biological pharmaceuticals; drug delivery agents for delivering pharmaceuticals to target cells; agents for delivering proteins to target cells; agents for delivering peptides to target cells; bacterial preparations for pharmaceutical purposes; bacterial preparations for medical purposes; micro-organisms, bacteria and cultures and preparations of micro-organisms for medical and veterinary use; media for the storage of micro-organisms and bacteria, bacteriological cultures; nutritive substances for micro-organisms; nutrients for microbial cultures; culture media for bacteriological cultures, bacteria and living microorganisms for medical and veterinary purposes; bacterial cultures for medical and veterinary use; cultures of microorganisms for medical and veterinary use; bacterial and bacteriological preparations for medical or veterinary use; diagnostic preparations and substances; pharmaceutical and veterinary preparations and substances; diagnostic preparations and substances, all for in vivo use; cell preparations for medical and veterinary purposes, nutrients for cell cultures; cell growth media for growing cells for medical use; living cells for medical use. |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 12, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 12, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 12, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NANOSYRINX LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, June 12, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 13, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 13, 2025 | APPLICATION FILING RECEIPT MAILED |
| Friday, August 22, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, September 9, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 10, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, October 24, 2025 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Friday, October 24, 2025 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Monday, October 27, 2025 | REFUSAL PROCESSED BY MPU |
| Monday, October 27, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 15, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, November 26, 2025 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |